HIMS Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Hims & Hers Health Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 12.5 USD 1.87%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast HIMS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HIMS is 16.03 USD with a low forecast of 11.11 USD and a high forecast of 21 USD.

HIMS Lowest Forecast

Wall Street Target

HIMS Average Forecast

Wall Street Target

HIMS Highest Forecast

Wall Street Target

11% Downside

28% Upside

68% Upside

The latest public price target was made on Apr 16, 2024 by Glen Santangelo from Jefferies , who expects HIMS stock to rise by 20% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Glen Santangelo Jefferies	15 USD Upside 20%	1 week ago Apr 16, 2024	Jefferies Downgrades Hims and Hers (HIMS) to Hold StreetInsider
Maria Ripps Canaccord Genuity	20 USD Upside 60%	2 weeks ago Apr 10, 2024	Canaccord Genuity Starts Hims and Hers (HIMS) at Buy, 'we see a healthy long-term opportunity' StreetInsider

Price Target	15 USD
Upside/Downside	20%

Price Target	20 USD
Upside/Downside	60%

Elan Corp

10% Upside

R1 RCM Inc

45% Upside

Kindstar Globalgene Technology Inc

101% Upside

InnovAge Holding Corp

76% Upside

Elan Corp

10% Upside

R1 RCM Inc

45% Upside

Kindstar Globalgene Technology Inc

101% Upside

InnovAge Holding Corp

76% Upside

Agiliti Inc

1% Upside

BML Inc

9% Upside

R1 RCM Holdco Inc

48% Upside

Gushengtang Holdings Ltd

46% Upside

Revenue
Forecast

The compound annual growth rate of Hims & Hers Health Inc's revenue for the next 3 years is 28%.

N/A

28%

-1%

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

-4%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-15%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for HIMS is 16.03 USD with a low forecast of 11.11 USD and a high forecast of 21 USD.

The compound annual growth rate of Hims & Hers Health Inc's revenue for the next 3 years is 28%.

Join more than 132,300+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.